Project Grant R21GM163205
- Federal Project Grant Award Summary The Ohio State University received a $416,726 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 11, 2025, through August 31, 2030. The award funds the development of mass spectrometry-based analytical technologies to enable chemical-specific measurements and proteomic analysis of organoids—three-dimensional cell cultures derived from...
- Federal Project Grant Award Summary Oregon Health & Science University received a $390,000 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. The award supports the development of novel methodologies for high-throughput characterization of extracellular RNA (cfRNA), cell-free DNA (cfDNA), and extracellular vesicles (EVs) in body fluids. The...
- Federal Project Grant Award Summary The University of Washington's Office of Sponsored Programs received a $427,625 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, with completion targeted for August 31, 2030. This grant supports the development of capillaric microfluidics technology designed to enable integrated, self-powered, and self-regulated sample...
- Federal Project Grant Award Summary The University of Oregon received a $398,464 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 6, 2026, with a completion date of December 31, 2030. This R35 award supports a five-year research initiative focused on developing innovative chemical tools and strategies to modulate reactive sulfur species (RSS), including hydrogen sulfide...
- Federal Project Grant Award Summary Oregon State University received a $399,081 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. The award supports fundamental research investigating the molecular mechanisms of lipid transfer by bridge-like lipid transfer proteins (BLTPs), a recently discovered and evolutionarily conserved protein...
- Federal Grant Award Summary Oregon State University received a $408,375 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on August 18, 2025, with completion targeted for July 31, 2030. The grant supports fundamental research aimed at uncovering the rules governing the spread of mobile genetic elements (MGEs)—diverse DNA elements such as plasmids and integrative and conjugative elements...
- Federal Project Grant Award Summary Purdue University received a $303,804 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 15, 2026 through February 28, 2029. The award funds the development of a highly sensitive correlative and multimodal molecular imaging platform utilizing nanospray desorption electrospray ionization mass spectrometry imaging (nano-DESI MSI)...
- Federal Project Grant Summary Harvard Medical School, operating through President and Fellows of Harvard College, received a $877,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) on April 16, 2025. The research initiative, which will conclude on January 31, 2030, focuses on developing and optimizing high-throughput mass spectrometry (MS)-based proteomics pipelines to enhance depth,...
- Federal Project Grant Award Summary Nanoengineering Corporation received a $338,843 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) awarded on June 15, 2025, with completion targeted for May 31, 2026. The grant supports the development of an electrospray differential mobility analysis (ES-DMA) soft-landing system designed to improve structural analysis of protein complexes using cryo-electron...
- Federal Grant Award Summary Oregon State University received a $148,680 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 14, 2025, with a completion date of June 30, 2030. The award supports the development and implementation of a new Ph.D. training program in Molecular Biophysics of Complex Systems (MBCS) at OSU. The program integrates faculty mentors from six primary...
Oregon State University received a $408,375 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through February 29, 2028. The award funds development and optimization of Thermal Ink Jet Spray (TIJ Spray), a novel ionization source technology designed to enable direct injection of low-input samples, including individual cells, into mass spectrometers for multi-omics analysis. When integrated with ion mobility mass spectrometry (IMMS) and high-resolution tandem mass spectrometers, TIJ Spray is intended to provide the necessary throughput, sensitivity, and specificity for detecting and characterizing cell type heterogeneity and drug response based on molecular ion profiles. The project deliverables include development and technical optimization of TIJ Spray in conjunction with IMMS systems, with analytical demonstration across multiple analyte classes relevant to single-cell analysis. The research will characterize proteome and metabolome profiles of individual cells to reveal functional phenotype heterogeneity, with particular application to understanding tumor microenvironments and discovering phenotype-specific biomarkers. This high-risk/high-reward initiative addresses a critical gap in current analytical capabilities where distinct cellular phenotypes are masked in bulk population analyses, thereby confounding drug discovery and biomarker validation efforts.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $408.4k | 2/27/26 |